×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

investors

GE Completes BioPharma Sale to Danaher, Receives $20 Billion Net Cash Proceeds

Tomas Kellner
March 31, 2020
header-image

GE announced the completion of the sale of its BioPharma business to Danaher on Tuesday. The company received approximately $20 billion in net cash proceeds.
Calling the sale “a critical milestone” in GE’s multiyear transformation, GE Chairman and CEO H. Lawrence Culp Jr. said the deal fortified the company’s “considerable sources to de-risk our balance sheet and continue to solidify our financial position.”

header-image

Leaping the biotech skills gap in Australia

Natalie Filatoff
July 26, 2019
Like the light, bright, undulating structure of the University of Technology’s Vicki Sara building in which it is housed, the University’s new $11.5 million Biologics Innovation Facility (BIF) is a future-focused, flexible response to student and industry needs.
header-image
Healthcare

GE To Sell Its BioPharma Unit For $21.4 Billion To Danaher

Tomas Kellner
February 25, 2019

GE announced plans on Monday to sell its BioPharma business to Danaher for approximately $21.4 billion, including $21 billion in cash. GE Chairman and CEO H. Lawrence Culp Jr. said the deal was a “pivotal milestone” that “demonstrates that we are executing on our strategy by taking thoughtful and deliberate action to reduce leverage and strengthen our balance sheet.”

Subscribe to biopharma